[1] Song F, Jia W, Yao Y, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed type 2 diabetes[J]. Clin Sci (Lond),2007,112(12):599-606. [2] Kaneto H, Katakami N, Kawamori D,et al. Involvement of oxidative stress in the pathogenesis of diabetes[J]. Antioxid Redox Signal,2007,9(3):355-366. [3] Chang T, Wang R, Wu L, et al. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells[J]. Free Radic Biol Med, 2005, 38(2): 286-293. [4] JeBailey L, Wanono O, Niu W, et al. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells[J]. Diabetes,2007,56(2):394-403. [5] Leiter LA, Lewanczuk RZ. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition[J]. Am J Hypertens, 2005,18(1): 121-128. [6] Honjo S, Yokote K, Fujishiro T, et al. Early amelioration of insulin resistance and reduction of interleukin-6 in Werner syndrome using pioglitazone[J]. J Am Geriatr Soc, 2008,56(1):173-174. [7] Teramoto T, Yamada N, Shirai K, et al. Effects of pioglitazone hydrochloride on Japanese patients with type 2 diabetes mellitus[J]. J Atheroscler Thromb, 2007, 14(2):86-93. [8] Li L, He Q, Huang X, et al.NOX3-derived reactive oxygen species promote TNF-α-induced reductions in hepatocyte glycogen levels via a JNK pathway[J]. FEBS Letters, 2010(584):995-1000. [9] 李兰芳,郭玉,唐国涛,等.吡咯列酮降低胰岛素抵抗状态下的氧化应激水平[J].中国临床药理学与治疗学,2010,15(2):140-144. [10] Masato K. Insulin resistance and atherosclerosis[J]. J Clin Invest, 2006,116(7):1756-1760. [11] Kasuga M. Insulin resistance and pancreatic β cell failure[J]. J Clin Invest , 2006,116(7):1756-1760. [12] 李兰芳,黄秀清, 原慧萍, 等. 吡格列酮改善胰岛素抵抗状态下氧化应激水平及分子机制探讨[J]. 中国临床药理学与治疗学,2009,14(3):245-249. |